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S(1.3% vs. 11.3%; p¼0.025). The 2-year cardiac survival was higher in patients with
a complete coronary revascularization as compared to patients with incomplete revas-
cularization (96%  3% vs. 78%  7%; p¼0.002); completeness of revascularization
was inversely related to the risk of death (HR 0.10; p¼0.029).
Conclusions: In patients with multiple CTOs a successful PCI of all CTOs was
associated with increased cardiac survival, and completeness of revascularization was
a strong predictor of survival.
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Background: CTO intervention is still challenging because of the limited procedural
success rate. The SYNTAX score is a unique tool to score complexity of coronary
artery disease involving CTO lesion, but, it isn't a speciﬁc for CTOs.
Methods: We evaluated whether the SYNTAX score focused on the evaluation of CTO
lesions (the Sys-CTO score)could predict successful revascularization for CTO-PCI or
not,compared with the J-CTO score.We investigated the Sys-CTO score and the J-CTO
score in consecutive 257 lesions treated with coronary angioplasty for CTOs. The Sys-
CTO score was availed focused on each CTO lesion by extracting from the SYNTAX
Calculator 2.11.The J-CTO score was determined by assigning one point for each
independent parameter using the J-CTO score sheet.
Results: Overall successful revascularization rate were 85.2% (219/257), and average
the Sys-CTO score and average the J-CTO score were 12.36.2, 1.751.30,
respectively.We divided all CTO lesions into two groups;the successful revascularized
groups(n¼219;SG):the failed revascularized groups(n¼38;FG).Relationship
between the value of the J-CTO score and successful revascularization rate(%)
were shown as follows ; (0):100,(1):93.4,(2):82.5,(3):67.4,(4):73.9,(5):66.7, respec-
tively. As for the J-CTO score,there were statistic difference between the two
groups;SG:1.6+/-1/3,FG:2.7+/-1.1(P<0.05).Whereas,as to the Sys-CTO score,
there were balanced between the two groups;SG:12.3+/-6.3,FG:12.3+/-5.2.In the
detailed evaluation of the Sys-CTO score,these distinctive six parameters seemed
to be predictive factors inhibiting successful revascularization(P30.05);Beyond the
segment visualized contrastS1segment(FG:34.2%;SG:25.1%),Blunt stump(FG:
63.1%;SG:45.2%), Bridging (FG:34.2%;SG:12.3%),Severe tortuosity(FG:26.3%;SG:
10.0%), Heavy calciﬁcation (FG:42.1%;SG:23.7%),Diffuse diseased and narrowed
segment(FG:36.8%;SG:31.5%).
Conclusions: The J-CTO score was reconﬁrmed as the predictor of a successful
revascularization for CTO-PCIs.On the other hand, the Sys-CTO score could not
be predictive factor by itself. However,these distinctive six parameters could be a useful
predictor of a successful revascularization for CTO-PCI as well as the J-CTO score.
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Background: There is a paucity of data on the long-term clinical outcomes of
successful percutaneous coronary intervention (PCI) of coronary chronic total
occlusions (CTOs) using the retrograde approach.
Methods:We performed a retrospective analysis of the long-term clinical outcomes of
193 consecutive patients who underwent successful CTO PCI at our institution
between December 2008 and December 2011.
Results:Mean age was 63.68.3 years, 98% of patients were men, 42% had diabetes,
20% had prior coronary artery bypass graft (CABG) surgery and 34% had prior PCI.
The retrograde approach was used in 41 patients (21.2%). The CTO target vessel was
more frequently the right coronary artery among patients who underwent retrograde
CTO PCI (78.1% vs. 45.7%, p¼0.001). The mean stent length was longer in the
retrograde group (8332 vs. 6432 mm, p¼0.001). During a median follow-up of 2.0
years (interquartile range, 1.36 to 3.22 years), compared to antegrade CTO PCI group,
patients who underwent retrograde CTO PCI had higher target lesion revascularization
(TLR) (45.6% vs. 25.7%, p¼0.006) (Figure 1). There was no signiﬁcant difference in
the incidence of all-cause mortality, myocardial infarction, non-target vessel revas-
cularization or CABG between the two groups.
Conclusions: Retrograde CTO PCI was associated with higher incidence of TLR, but
similar incidence of death and myocardial infarction. These ﬁndings likely reﬂect theJACC Vol 62/18S1/Suppl B j October 27–November 1, 2013 j TCT Abhigher complexity of CTO lesions and long stent lengths needed in those treated with
the retrograde approach.TCT-365
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Background: Coronary chronic total occlusion (CTO) is frequently associated with
multivessel disease. Large registries have shown a higher mortality in patients with
unsuccessful CTO-PCI for left anterior descending artery (LAD) as compared to
nonLAD-CTO. Furthermore, patients with incomplete coronary revascularization due
to non attempted or failed CTO-PCI had a poor prognosis as compared to patients with
a complete revascularization. No data exist about the prognostic impact of drug eluting
stent (DES) supported successful PCI for LAD-CTO in patients with a complete
coronary revascularization achieved by PCI.
Methods: From the prospective Florence CTO-PCI registry, since 2004 to 2010, 644
patients underwent a successful PCI for CTO (>3 months) with a complete coronary
revascularization within one month. The prognostic impact of LAD-CTO on cardiac
mortality was assessed by Kaplan-Meier estimation and by forward stepwise Cox
regression multivariate analysis.
Results: A successful CTO-PCI with a complete coronary revascularization was
achieved in 194 patients with LAD-CTO and in 450 patients with nonLAD-CTO.
Baseline characteristics of patients with LAD-CTO vs. nonLAD-CTO were similar:
mean age 68  11 vs. 67  11 yrs, male 83% vs. 86%, diabetes 22% vs. 23%,
previous myocardial infarction 51% vs. 48%, acute coronary syndrome at admission
34% vs. 29%, 3-vessel coronary disease 43% vs. 48%, left ventricular ejection fraction
(EF) 44%  13 vs. 45%  12, stent length >40 mm in LAD-CTO 51% vs. 57% in
non-LAD-CTO. A multivessel PCI was performed in 70% of both groups. The clinical
follow-up rate was 100% (median 1 yr). The cardiac survival rate was higher in the
nonLAD-CTO group as compared to LAD-CTO group (96%  2% vs 89%  3%;
p¼0.004). At multivariate analysis the independent predictors related to cardiac
mortality were LAD-CTO (HR 2.9; p¼0.025), age (HR 1.1; p¼0.002) and EF <0.40
(HR 14; p<0.001).
Conclusions: The successful treatment of nonLAD-CTO associated with a complete
revascularization links with a very high survival rate. LAD-CTO is a predictor of
cardiac mortality despite the completeness of coronary revascularization.
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Background: Little data is available about safety, feasibility, and long-term outcome
after retrograde CTO PCI. This study sought to examine the short and long-term
outcomes of retrograde chronic total occlusion (CTO) percutaneous coronary inter-
vention (PCI).
Methods: From a single-center prospective registry, 1343 consecutive patients
underwent CTO PCI from January 2004 to January 2012.
Results: Of these, 144 (10.7%)had retrogradeCTOPCI (0, 1.3, 10.2, 6.2, 15.6, 10.9, 16.1,
23.4% from 2004 to 2011). Patients with retrograde CTO were signiﬁcantly younger
(61.210.7 vs 63.911.4 years, p<0.01), more frequently dyslipidemic (72.9 vs 62.3%,
p<0.01), right coronary artery CTO (65.3 vs 43.7%, p<0.01), longer lesion length
(27.221.9 vs 19.616.5 mm, p<0.01) and less tapered morphology (31.7 vs 46.5%,
p<0.01). Procedural success rate of antegrade and retrograde approach was 73.7 andstracts/POSTER/Chronic Total Occlusions B115







S70.8% (p¼0.46). Coronary perforations (10.5 vs 3.0%, p<0.01) and need for pericardial
drainage (3.6 vs 1.0%, p¼0.02) were more frequent among retrograde compared to
antegrade approach. However, need for emergency cardiac surgery were similar (0 vs
0.9%,p¼0.57).RetrogradeCTOPCIwas relatedwith longer procedure time (149.758.6
vs 80.740.2 min. p<0.01), ﬂuoroscopy time (75.839.1 vs 42.599.8 min. p<0.01)
and higher contrast dose (385180 vs 257158ml, p<0.01). The incidence of in-hospital
non Q-wave myocardial infarction (0.7 vs 0.1%, p¼0.20) and death were similar (0.7 vs
1.1%, p¼0.66). The 3-year cumulative incidence ofmyocardial infarction (2.6% vs 1.3%,
p¼0.81) and cardiac death (4.8% vs 4.7%, p¼0.83) were similar between retrograde and
antegrade approach. Among patients with successful CTO PCI, the 3-year cumulative
target lesion revascularization (TLR) rate was signiﬁcantly higher in retrograde approach
compared with antegrade (12.6% vs 6.9%, p¼0.045).
Conclusions: Higher incidences of coronary perforation and pericardial drainage, but
no emergency cardiac surgery were observed after retrograde CTO PCI. Although
long-term TLR rate was higher, retrograde CTO PCI was associated with acceptable
procedural success rate and similar short and long-term adverse events compared with
antegrade CTO PCI.
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Background:Whether successful PCI of a coronary CTO is associated with improved
survival is the subject of debate. Using a large prospective database of patients treated
for CTO, we sought to compare long-term outcome of patients on the basis of success/
failure of the index PCI procedure.
Methods: Between 2004 and 2012, a total of 1,343 consecutive patients underwent
PCI for CTO in our centre (14 operators). We compared major adverse cardiac events
(MACE) including cardiac death, target vessel revascularisation (TVR), and
myocardial infarction (MI) in patients with successful versus failed PCI at a median
follow up of 4.1 years (IQR: 2.4-6.5 years). Procedural success was deﬁned as
achievement of residual stenosis <50% with TIMI-3 ﬂow in the target vessel.
Results: Successful treatment of CTO by PCI was achieved in 1000 (74%) patients.
These patients were younger (6311 vs. 6511 respectively p¼0,02), had lower rates
of hypertension (56.1% vs. 66.8% p<0,01), previous MI (19.5 % vs. 29.2% p<0,01)
and were more frequently treated for left anterior descending artery CTO (33.2 vs.
23.0%, p<0.01) than those in whom PCI success was not achieved. However, left
ventricular ejection fraction and diabetes mellitus were similar between groups. PCI
success was associated with signiﬁcantly lower MACE among patients with
successful PCI (16.7 vs. 22.2%, p¼ 0.0235) driven mainly by lower rate of cardiac
death at follow up (4.2 vs. 11%, p<0.0001). Independent predictors of lower cardiac
death by multivariate analysis were: successful PCI (HR: 0,42, 95% CI: 0.27-0.67,
p < 0.01), absence of previous MI (HR: 1.68, 95% CI: 1.03-2.74, p ¼0.04) and
younger age (HR: 1.05, 95% CI: 1.03-1.08, p < 0.01).
Conclusions: In this large cohort of patients treated by PCI for CTO, successful
revascularization was associated with improved clinical outcome at long-term follow-
up. This was driven by lower cardiac mortality rates among these patients.
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Background: To assess the procedural success rate and the long-term clinical impact
of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) in
elderly patients.
Methods: A total of 1,343 consecutive patients with underwent PCI for 1,432 CTO
lesions between Jan 2004 and Jan 2012 at our center. Outcomes including procedural
success and major adverse cardiac events (MACE) and its components, cardiac death,
myocardial infarction and target vessel revascularization between patients aged 75
and patients aged <75 years were compared.
Results: A total of 253 patients (19%) were aged 75 years. Compared to patients
<75 years, elderly patient were more commonly female (20% vs. 11.8%, p<0.0001)
and presented most commonly with left anterior descending coronary artery CTO
(41.5% vs. 28.5%, p¼0.001). Procedural success rates were similar in both groups
(74.9% vs. 72.7%, p ¼ 0.48). Median follow-up was 4.1 years (IQR: 2.4-6.5 years).
MACE rates after successful versus failed PCI were 20.9% versus 29.8% in the elderly
(p ¼ 0.15) and 21.0 versus 24.1% in younger patients (p ¼ 0.12). In elderly patients,
this trend in reduction in MACE after successful PCI was driven by a signiﬁcant
reduction in cardiac mortality (Figure). There was also a signiﬁcant reduction in all-
cause mortality (21.1% vs. 35.9%, p ¼ 0.02) and no signiﬁcant differences in the rate
of MI (2.8% vs. 1.6%, p ¼ 0.597).B116 JACC Vol 62/18S1/Suppl B j October 27–NConclusions: PCI for CTO has similar success rate in the elderly (75 years) and is
associated with a signiﬁcant reduction in cardiac mortality when success is achieved.TCT-369
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Background: Routine follow-up angiogram data after successful recanalization of
chronic total coronary occlusions (CTO) with a long total stent length (SL) are
lacking. In the present study, we evaluated clinical and angiographic outcomes after
successful recanalization of CTO with implantation of a long total SL.
Methods: Routine follow-up angiogram were performed at 6 months after successful
recanalization of 113 CTO (antegrade approach in 81% and retrograde approach in
19%) with a long SL ( 20mm) in 108 consecutive patients.
Results: Mean number of stents was 3.8  1.8 and mean total SL was 76  33 mm
(range 20-174 mm). Drug-eluting stents (DES) were used in 106 lesions with siroli-
mus-eluting stents (SES) in 100. Instent total reocclusion occurred in 2 DES lesions
(1 SES and 1 DES non-SES). Restenosis rate was 18% in DES vs 71% in bare
metal stents group (p ¼ 0.004). In the 100 SES sub-group (total SL 79  33mm, range
23-174 mm and mean number of stents 3.9  1.8) restenosis rate was 18%; a younger
age and a longer total SL were found to be independent predictors of restenosis (HR
0.939, 95% CI 0.885-0.996, p ¼ 0.035 and HR 1.017, 95% CI 1.00-1.03 p ¼ 0.045,
respectively); restenosis type was diffuse in only 11% and 89% were successfully
treated by repeat percutaneous coronary intervention. During a median follow-up of 2
years (interquartile range: 1 to 4.3 years), major cardiac events other than those
angiographically driven at routine follow-up angiogram occurred in 3 patients (cardiac
surgery at 7, 8 and 9 months, respectively).
Conclusions: Angiographic restenosis rate remains acceptable in patients with complex
CTO successfully treated by a long total length ofDES and restenosis can be successfully
treated by repeat percutaneous coronary intervention in the vast majorty of cases.
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Background: Chronic Total Occlusions (CTOs) are commonly encountered in
patients (PTs) with Acute Coronary Syndromes (ACS). It has been reported that the
presence of a CTO is associated with increased mortality in PTs presenting with ST
elevation Myocardial Infarctions (STEMI). It is less clear if this same association is
true for PTs presenting with non-STE ACS (NSTEACS).
Methods: The Minneapolis Heart Institute has developed standard treatment protocols
for STEMI (Level 1, L1) and NSTEACS (Level 2, L2) PTs. From 2007-2011, 2062
sequential STEMI PTs and from 2009-2012, 827 sequential NSTEACS PTs who
underwent angiography were evaluated for the presence of at least one CTO in a major
coronary vessel. In-hospital, 30 day, and 1 year mortality were compared between PTs
who did and did not have a CTO.
Results: See table below:ovember 1, 2013 j TCT Abstracts/POSTER/Chronic Total Occlusions
